Literature DB >> 16978056

Horse embryonic stem cell lines from the proliferation of inner cell mass cells.

Xihe Li1, S G Zhou, Marta P Imreh, L Ahrlund-Richter, W R Allen.   

Abstract

Inner cell mass (ICM) cells were isolated immunosurgically from day 7-8 horse blastocysts and, after proliferation in vitro for 15-28 passages, three lines of cells were confirmed to be embryonic stem (ES) cells by their continued expression of alkaline phosphatase activity and their ability to bind antisera specific for the recognized stem cell markers, SSEA-1, TRA-1-60, TRA-1-81, and the key embryonic gene Oct-4. When maintained under feeder cell-free conditions in vitro, the three lines of cells differentiated into cells of ectodermal, endodermal, and mesodermal lineages. However, they did not form teratomata when injected into the testes of severe combined immunodeficiency (SCID)/beige immunoincompetent mice, thereby indicating a significant difference in phenotype between ES cells of the horse and those of the mouse and human.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978056     DOI: 10.1089/scd.2006.15.523

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  21 in total

Review 1.  The pursuit of ES cell lines of domesticated ungulates.

Authors:  Neil C Talbot; Le Ann Blomberg
Journal:  Stem Cell Rev       Date:  2008-07-09       Impact factor: 5.739

Review 2.  Translating stem cell therapies: the role of companion animals in regenerative medicine.

Authors:  Susan W Volk; Christine Theoret
Journal:  Wound Repair Regen       Date:  2013-04-29       Impact factor: 3.617

3.  Embryonic stem cells and iPS cells: sources and characteristics.

Authors:  Catherine H Hackett; Lisa A Fortier
Journal:  Vet Clin North Am Equine Pract       Date:  2011-06-16       Impact factor: 1.792

4.  Generation and characterization of leukemia inhibitory factor-dependent equine induced pluripotent stem cells from adult dermal fibroblasts.

Authors:  Deanne J Whitworth; Dmitry A Ovchinnikov; Jane Sun; Patrick R J Fortuna; Ernst J Wolvetang
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

Review 5.  Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?

Authors:  Jan H Spaas; Deborah J Guest; Gerlinde R Van de Walle
Journal:  Sports Med       Date:  2012-10-01       Impact factor: 11.136

Review 6.  Concepts for the clinical use of stem cells in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2008-10       Impact factor: 1.008

7.  Three-dimensional culture and transforming growth factor beta3 synergistically promote tenogenic differentiation of equine embryo-derived stem cells.

Authors:  Tom Barsby; Emma P Bavin; Debbie J Guest
Journal:  Tissue Eng Part A       Date:  2014-04-21       Impact factor: 3.845

8.  Induced pluripotent stem cell lines derived from equine fibroblasts.

Authors:  Kristina Nagy; Hoon-Ki Sung; Puzheng Zhang; Simon Laflamme; Patrick Vincent; Siamak Agha-Mohammadi; Knut Woltjen; Claudio Monetti; Iacovos Prodromos Michael; Lawrence Charles Smith; Andras Nagy
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

9.  Induction of pluripotency in adult equine fibroblasts without c-MYC.

Authors:  Khodadad Khodadadi; Huseyin Sumer; Maryam Pashaiasl; Susan Lim; Mark Williamson; Paul J Verma
Journal:  Stem Cells Int       Date:  2012-03-19       Impact factor: 5.443

10.  Derivation and characterization of induced pluripotent stem cells from equine fibroblasts.

Authors:  Amandine Breton; Ruchi Sharma; Andrea Catalina Diaz; Alea Gillian Parham; Audrey Graham; Claire Neil; Christopher Bruce Whitelaw; Elspeth Milne; Francesc Xavier Donadeu
Journal:  Stem Cells Dev       Date:  2012-09-28       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.